New York, New York, United States Walgreens appeared to be the Corporate Investor, which was created in 1901. The main department of described Corporate Investor is located in the Deerfield. The company was established in North America in United States.
The fund has specific favorite in a number of founders of portfolio startups. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Theranos, TytoCare, MedAvail. Among the most popular fund investment industries, there are Consumer, Health Care.
The fund is constantly included in less than 2 deals per year. The usual things for fund are deals in the range of 10 - 50 millions dollars. Speaking about the real fund results, this Corporate Investor is 0 percentage points less often commits exit comparing to other organizations. The important activity for fund was in 2014.
The usual cause for the fund is to invest in rounds with 5 partakers. Despite the Walgreens, startups are often financed by Teuza, OrbiMed, LionBird. The meaningful sponsors for the fund in investment in the same round are OrbiMed, LionBird, Fosun Group. In the next rounds fund is usually obtained by OrbiMed, LionBird, ITOCHU Corporation.
| Fund Name | Location |
| Arthur Rock & Co | - |
| Bran Investments | - |
| COTEC Portugal | - |
| DeGeorge Holdings | - |
| French Public Bank of Investment | - |
| iPS Academia Japan | Japan, Kantō, Mikuruba |
| JioSaavn | India, Maharashtra, Mumbai |
| Kaizen Private Equity | Central Region, Singapore, Singapore |
| Leimei Ruisi | Chengguan District, China, Lhasa |
| Marsh & McLennan Companies | New York, New York, United States |
| Pavey Family Investments | - |
| Peregrine Systems | Minneapolis, Minnesota, United States |
| Richland Ventures | Nashville, Tennessee, United States |
| Shenzhen Sidu Kongjian Touzi Co., Ltd. | China, Guangdong, Shenzhen |
| Via ID | France, Marquette Lez Lille, Nord-Pas-de-Calais |
| Zhongnan Jituan | - |
| Zixian Investment | Beijing, Beijing, China |
| ZopSmart | Bangalore, India, Karnataka |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
TytoCare | $27M | 29 Jan 2018 | New York, New York, United States | ||
TytoCare | $12M | 14 Jul 2015 | New York, New York, United States | ||
MedAvail | $30M | 16 Oct 2014 | Mississauga, Ontario, Canada | ||
TytoCare | $7M | 18 Mar 2014 | New York, New York, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
TytoCare | $27M | 29 Jan 2018 | New York, New York, United States | ||
TytoCare | $12M | 14 Jul 2015 | New York, New York, United States | ||
MedAvail | $30M | 16 Oct 2014 | Mississauga, Ontario, Canada | ||
TytoCare | $7M | 18 Mar 2014 | New York, New York, United States |
